X4 Pharmaceuticals to Report Fourth-Quarter and Full-Year
BOSTON, March 07, 2023 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals, Inc. (Nasdaq: XFOR), a leader in the discovery and
Globe Newswire7-03-2023, 20:04
ETC Awarded $17.3 Million Contract for its Sterilization Systems Group 30-06-2023, 03:47